Herbes de Provence packaged in the following ways: 1) World Market, Organic Herbs De Provence, Net Wt. 0.6 OZ (17 g), Distributed by C...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0038-2021.
An ingredient (parsley) which was repacked into consumer packages and used to manufacture other herb blends tested positive for Salmonella and was recalled by the supplier.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0038-2021.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Red Monkey Foods Inc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0038-2021.
Red Monkey Foods Inc
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Red Monkey Foods Inc Recall FAQ
Red Monkey Foods Inc is the subject of a food safety report: Herbes de Provence packaged in the following ways: 1) World Market, Organic Herbs De Provence, Net Wt. 0.6 OZ (17 g), Distributed by C.... The notice was published on October 9, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 446 units are potentially affected.